Override
PrivateLast Round
Seed Round
Jun 18, 2026
Total Funding Raised
$3.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Override is a digital healthcare company that operates a virtual platform providing comprehensive, team-based care to control chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Mental Health
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Override Comparables
Compare Override with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lin Health | 85% | |
| MoreGoodDays | 83% | |
| Dorsal Health | 79% | |
Override Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 18, 2026 | ||||
| Seed | Dec 15, 2022 |
Override Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 7wire Ventures | Seed |
| SignalFire | Seed |
| Martin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$2.1M seed round completed.
- Dec 15, 2022
$4M round led by 7wire Ventures and Martin Ventures.
Override Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Override's valuation, stock price, and market status.